CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids

Dorian R. A. Swarts, Mieke E. R. Henfling, Leander Van Neste, Robert-Jan van Suylen, Anne-Marie C. Dingemans, Winand N. M. Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, Wim Van Criekinge, Manon van Engeland, Frans C. S. Ramaekers, Ernst-Jan M. Speel

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)2197-2207
JournalClinical Cancer Research
Volume19
Issue number8
DOIs
Publication statusPublished - 15 Apr 2013

Cite this

Swarts, D. R. A., Henfling, M. E. R., Van Neste, L., van Suylen, R-J., Dingemans, A-M. C., Dinjens, W. N. M., Haesevoets, A., Rudelius, M., Thunnissen, E., Volante, M., Van Criekinge, W., van Engeland, M., Ramaekers, F. C. S., & Speel, E-J. M. (2013). CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids. Clinical Cancer Research, 19(8), 2197-2207. https://doi.org/10.1158/1078-0432.CCR-12-3078